Shanghai, China – On August 3, Shanghai MicroPort Medical (Group) Co., Ltd. ("MicroPort®") was awarded "Pudong Model Enterprise with Well-known Brand in International Trade" by Shanghai Pudong District Government during the China (Shanghai) Free Trade Zone & Pudong District Trade Facilitation Measure Press Conference.
Weihua Shen, Deputy Director of Shanghai Municipal Commission of Commerce, Fangzhou Lu, Deputy Director of China (Shanghai) Pilot Free Trade Zone Management Committee, member of the standing committee of Pudong District Committee, and Deputy Head of Pudong District, Danian Jian, Inspector of China (Shanghai) Pilot Free Trade Zone Management Committee, Guozhu Xie, Secretary of CPC Leadership Group of Shanghai Pudong Customs and Director of Shanghai Pudong Customs, and Xingwei Zou, Pudong Entry-Exit Inspection and Quarantine Bureau, attended the conference. In total, the conference gathered over 500 attendees from Shanghai Municipal Commission of Commerce, Shanghai Pudong Customs, Pudong Entry-Exit Inspection and Quarantine Bureau, other Pudong governmental departments, Pudong international trade companies, and industry associations. The conference aims to push forward the trade facilitation reform in Shanghai Free Trade Zone under the guidance of "the Plan to Comprehensively Deepen the Reform and Opening-up in China (Shanghai) Pilot Free Trade Zone" by the State Council, as well as to present the construction achievements of Shanghai Free Trade Zone and the Core Area of Pudong International Trade Center.
Fangzhou Lu, Deputy Director of China (Shanghai) Pilot Free Trade Zone Management Committee, member of the standing committee of Pudong district committee, and Deputy Head of Pudong District, said: "Brand building is always listed among companies' core strategies as brand image plays an important role in business and trade. We are glad to see several Pudong companies have built internationally well-known brand, which help them to win market share and may hopefully lead more domestic companies to capture overseas markets."
Through years of growth and innovation, MicroPort® has become a premier multinational medical solution provider, with over 200 products currently approved for use in over 5,000 hospitals in Asia Pacific, Europe, America and etc., MicroPort® is contributing to a better world through its life-saving medical therapies and quality-improving care devices being used in patients every 15 seconds, to help save a life, or improve quality of life or create new life for nearly 10 million patients worldwide. MicroPort® set up production and R&D facilities in Shanghai, Jiangsu, Zhejiang, Beijing, Shenzhen, and Memphis of the US. By mergers and acquisition, MicroPort® is taking solid steps in becoming a truly global player. MicroPort® has a global workforce of more than 3,000 employees of which one third are overseas employees. MicroPort® is committed to becoming a patient-oriented global enterprise in minimally invasive and other emerging medical technology industries, and will actively respond to the "Belt and Road" initiative to introduce safe, effective, affordable, and high-end China-developed products to more patients worldwide.